RayzeBio inc (DELISTED) (RYZB:DL)
62.49
0.00 (0.00%)
USD |
NASDAQ |
Mar 06, 16:00
RayzeBio Total Liabilities (Quarterly): 28.19M for Sept. 30, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2023 | 28.19M |
| June 30, 2023 | 441.25M |
| Date | Value |
|---|---|
| December 31, 2022 | 436.07M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
28.19M
Minimum
Sep 2023
441.25M
Maximum
Jun 2023
301.84M
Average
436.07M
Median
Dec 2022
Total Liabilities (Quarterly) Benchmarks
| Bristol-Myers Squibb Co | 82.48B |
| Karuna Therapeutics Inc (DELISTED) | 81.97M |
| Ambrx Biopharma Inc (DELISTED) | 29.10M |
| Pfizer Inc | 128.54B |
| Mirati Therapeutics Inc (DELISTED) | 183.24M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 603.51M |
| Shareholders Equity (Quarterly) | 575.32M |